NCT01905202View on ClinicalTrials.gov

The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus

PHASE1UnknownINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2015

Conditions
Barrett's Esophagus
Interventions
DRUG

Secretrol

Trial Locations (1)

64128

Veteran's Administration Medical Center, Kansas City

Sponsors
All Listed Sponsors
lead

Effexus Pharmaceutical

INDUSTRY

NCT01905202 - The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus | Biotech Hunter | Biotech Hunter